Anti-HMGCR Myopathy without Exposure to Statins: A Case Report

Anti-HMGCR, which was first identified in 2010, has emerged as an important mechanism of myopathogenesis in patients with exposure to statins. The availability of new detection methods has expanded the phenotypic spectrum with a subtype of population that hasn’t been exposed to the drug and whose cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferriz Vivancos, Jorge, Sánchez, Marta Fandos, Timoneda, Pilar Teresa Timoneda, Benito, Goitzane Marcaida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768615/
https://www.ncbi.nlm.nih.gov/pubmed/36605298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768615/
https://www.ncbi.nlm.nih.gov/pubmed/36605298

Ejemplares similares